EFFECTS OF NINTEDANIB ON CIRCULATING BIOMARKERS IN PATIENTS WITH PROGRESSIVE FIBROSING AUTOIMMUNE DISEASE-RELATED INTERSTITIAL LUNG DISEASES

被引：0
|
作者：
Maher, T. [1 ,2 ]
Bonella, F. [3 ]
Assassi, S. [4 ]
Noth, I. [5 ]
Diefenbach, C. [6 ]
Ittrich, C. [7 ]
Rohr, K. [8 ]
Kolb, M. [9 ,10 ]
机构：
[1] Imperial Coll London, Natl Heart & Lung Inst, London, England
[2] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[3] Duisburg Essen Univ, Ruhrlandklin Univ Hosp, Ctr Interstitial & Rare Lung Dis, Essen, Germany
[4] Univ Texas Houston, Div Rheumatol, McGovern Med Sch, Houston, TX USA
[5] Univ Virginia, Div Pulm & Crit Care Med, Charlottesville, VA USA
[6] Boehringer Ingelheim Pharma GmbH Co KG, Translat Med & Clin Pharmacol, Biberach, Germany
[7] Boehringer Ingelheim Pharma GmbH Co KG, Global Biostat & Data Sci, Biberach, Germany
[8] Boehringer Ingelheim Int GmbH, TA Inflammat Med, Ingelheim, Germany
[9] McMaster Univ, Div Respirol, Hamilton, NY USA
[10] St Josephs Healthcare, Div Respirol, Hamilton, NY USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Clinical trials; Lungs; Biomarkers;
D O I：
10.1136/annrheumdis-2023-eular.1557
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0845
引用
收藏
页码：722 / 722
页数：1
相关论文
共 50 条
  • [1] Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial
    Matteson, Eric L.
    Kelly, Clive
    Distler, Joerg H. W.
    Hoffmann-Vold, Anna-Maria
    Seibold, James R.
    Mittoo, Shikha
    Dellaripa, Paul F.
    Aringer, Martin
    Pope, Janet
    Distler, Oliver
    James, Alexandra
    Schlenker-Herceg, Rozsa
    Stowasser, Susanne
    Quaresma, Manuel
    Flaherty, Kevin R.
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 (06) : 1039 - 1047
  • [2] Effects of Nintedanib on Circulating Biomarkers in Subjects with Progressive Fibrosing Interstitial Lung Diseases (ILDs)
    Maher, T. M.
    Jenkins, R. G.
    Bonella, F.
    Assassi, S.
    Diefenbach, C.
    Ittrich, C.
    Rohr, K. B.
    Kolb, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [3] Effects of Nintedanib in Patients with Progressive Fibrosing Autoimmune Disease-related Interstitial Lung Diseases (ILDs) in the INBUILD Trial: Subgroups by HRCT Pattern
    Dellaripa, Paul
    Aringer, Martin
    Mann-Vold, Anna Maria Hoff
    Kelly, Clive
    Mittoo, Shikha
    James, Alexandra
    Rohr, Klaus
    Stowasser, Susanne
    Inoue, Yoshikazu
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [4] Continued Treatment with Nintedanib in Patients with Progressive Fibrosing Autoimmune Disease-Related Interstitial Lung Diseases: Data from INBUILD-ON
    Matteson, Eric
    Antin--Ozerkis, Danielle
    Bonella, Francesco
    Chaudhuri, Nazia
    Cottin, Vincent
    Mueller, Heiko
    Coeck, Carl
    Rohr, Klaus B.
    Wuyts, Wim A.
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 372 - 373
  • [5] Continued Treatment with Nintedanib in Patients with Progressive Fibrosing Autoimmune Disease-Related Interstitial Lung Diseases (ILDs): Data from INBUILD-ON
    Matteson, Eric
    Antin-Ozerkis, Danielle
    Bonella, Francesco
    Chaudhuri, Nazia
    Cottin, Vincent
    Mueller, Heiko
    Coeck, Carl
    Rohr, Klaus
    Wuyts, Wim
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 260 - 262
  • [6] Reduced Decline in Forced Vital Capacity in Patients with Progressive Fibrosing Autoimmune Disease-Related Interstitial Lung Diseases (ILDs) Treated with Nintedanib
    Matteson, Eric
    Distler, Oliver
    Distler, Joerg H. W.
    Kuwana, Masataka
    Pope, Janet
    Seibold, James
    James, Alexandra
    Schlenker-Herceg, Rozsa
    Rohr, Klaus
    Flaherty, Kevin
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [7] The INBUILD Trial of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases: Subgroup with Autoimmune Diseases
    Matteson, Eric
    Kelly, Clive
    Distler, Joerg
    Mann-Vold, Anna Maria Hoff
    Seibold, James
    Mittoo, Shikha
    Distler, Oliver
    Goeldner, Rainer-Georg
    Schlenker-Herceg, Rozsa
    Stowasser, Susanne
    Quaresma, Manuel
    Flaherty, Kevin
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [8] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
    Kao, Jui-Hung
    Huang, Hsin-Tuan
    Li, Ko-Jen
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (08): : 780 - 781
  • [9] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
    Flaherty, K. R.
    Wells, A. U.
    Cottin, V
    Devaraj, A.
    Walsh, S. L. F.
    Inoue, Y.
    Richeldi, L.
    Kolb, M.
    Tetzlaff, K.
    Stowasser, S.
    Coeck, C.
    Clerisme-Beaty, E.
    Rosenstock, B.
    Quaresma, M.
    Haeufel, T.
    Goeldner, R-G
    Schlenker-Herceg, R.
    Brown, K. K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (18): : 1718 - 1727
  • [10] Nintedanib in progressive fibrosing interstitial lung diseases
    Hadjiski, D.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (04): : 393 - 394
12345